MBX Biosciences, Inc. MBX
CIK 0001776111
Form 3 statements with an event date from Nov 1, 2023 to Nov 7, 2026.
Where insider ownership starts.
Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.
| Holdings date | Insider | Initial holdings | |
|---|---|---|---|
| Sep 12, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Yang Rick 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Walker Paul Edward 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Hawryluk P. Kent President & CEO · Director | 2 stock holdings · 7 derivative holdings | ▾ |
| Sep 12, 2024 | SANDELL SCOTT D 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Mathers Edward T Director · 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Makhzoumi Mohamad 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Florence Anthony A. Jr. 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Chang Carmen 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Behbahani Ali 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | CORNELIUS JAMES M Director | 4 derivative holdings | ▾ |
| Sep 12, 2024 | BASKETT FOREST 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Heron Patrick J Director · 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | New Enterprise Associates 17, L.P. · NEA Partners 17, L.P. · NEA 17 GP, LLC 10% owner / 10% owner / 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | Pescovitz Ora H. Director | 16.64K shares · 1 derivative holding | ▾ |
| Sep 12, 2024 | Aynechi Tiba Director | 1 derivative holding | ▾ |
| Sep 12, 2024 | Ryder Steven Director | 1 derivative holding | ▾ |
| Sep 12, 2024 | GORDON CARL L Director · 10% owner | 3 derivative holdings | ▾ |
| Sep 12, 2024 | Topper James N · FHMLS X, L.L.C. · Frazier Life Sciences X, L.P. · FHMLS X, L.P. 10% owner / 10% owner / 10% owner / 10% owner | 2 derivative holdings | ▾ |
| Sep 12, 2024 | ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Genesis GP LLC Director · 10% owner / Director · 10% owner / Director · 10% owner | 3 derivative holdings | ▾ |
| Sep 12, 2024 | Azoulay Salomon Chief Medical Officer | 1 derivative holding | ▾ |
| Sep 12, 2024 | Bartram Richard Chief Financial Officer | 3 derivative holdings | ▾ |
Showing 22 / 22 statements in 2024. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2024, this page lists 22 of 22 statements.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_initial_holdings
{"action":"list","ticker":"MBX","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.